Tag: poultry vaccines market growth

Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.

Poultry Vaccines Market Forecast: Value Set To Climb From $2.12 Billion To $3.04 Billion

The poultry vaccines market size has demonstrated robust expansion over recent years. Its valuation is projected to increase from $1.94 billion in 2025 to $2.12 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 9.4%. Historically, this market’s expansion was driven by factors such as outbreaks of avian diseases, an uptick in poultry consumption, advancements in traditional vaccine development, heightened veterinary awareness at the farm level, and the growth of commercial poultry farming.

The poultry vaccines market size is projected to experience substantial growth in the upcoming years. By 2030, it is anticipated to expand to $3.04 billion, demonstrating a compound annual growth rate (CAGR) of 9.5%. This projected growth during the forecast period can be attributed to the rise of recombinant and DNA vaccines, the adoption of precision poultry vaccination programs, technological advancements in vaccine delivery systems, government initiatives aimed at improving poultry health, and an increasing focus on biosecurity measures within poultry farms. Major trends expected in this period include the increased usage of live and inactivated poultry vaccines, a greater emphasis on disease prevention in broilers and layers, the broader application of recombinant and DNA vaccines, the integration of vaccination programs with broader farm management practices, and the development of robust cold chain infrastructure for poultry vaccine distribution.

Get A Free Sample Report With In-Depth Market Insights:

https://thebusinessresearchcompany.com/sample_request?id=8622&type=smp&name=Poultry%20Vaccines%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Poultry Vaccines Market Demand Drivers: What’s Powering Industry Growth?

The escalating occurrence of zoonotic diseases is anticipated to stimulate the expansion of the poultry vaccine market in the coming period. These common diseases are caused by pathogenic germs such as viruses, bacteria, parasites, and fungi. The growing prevalence of zoonotic diseases is increasing due to heightened human–animal interaction, as expanding urbanization and livestock farming lead to closer contact between people and animals. The poultry vaccine market is bolstered by the rising prevalence of zoonotic diseases, given that elevated disease risks necessitate vaccination to hinder the transmission of infections from poultry to humans and safeguard the health of flocks. For instance, in December 2025, according to European Centre for Disease Prevention and Control, a Sweden-based government agency, in 2024, the five most reported zoonoses in humans were campylobacteriosis, with 168,396 cases (55.3 cases per 100,000 people), salmonellosis, with 79,703 cases (18.6 cases per 100,000 people), Shiga toxin-producing Escherichia coli (STEC) infections, with 11,738 cases (3.5 cases per 100,000 people) and echinococcosis, with 984 cases (0.22 cases per 100,000 people). Therefore, the increasing prevalence of zoonotic diseases is expected to drive the growth of poultry vaccines.

Poultry Vaccines Market Segment Performance And Emerging Opportunities

The poultry vaccines market covered in this report is segmented –

1) By Type: Porcine Vaccines, Poultry Vaccine, Livestock Vaccine, Companion Animal Vaccine, Aquaculture Vaccines, Other Animal Vaccines

2) By Disease Type: Avain Influenza, Infectious Bronchitis

3) By Dosage Form: Liquid Vaccine, Freeze Dried Vaccine, Duct

4) By Technology: Toxoid, Live Attenuated Vaccines, Recombinant Vaccines, Inactivated Vaccines

5) By Application: Broiler, Layer, Breeder

Subsegments:

1) By Porcine Vaccines: Inactivated Vaccines, Live Attenuated Vaccines, DNA Vaccines, Recombinant Vaccines, Toxoid Vaccines

2) By Poultry Vaccines: Live Vaccines, Inactivated Vaccines, Recombinant Vaccines, Subunit Vaccines, DNA Vaccines

3) By Livestock Vaccines: Bovine Vaccines, Swine Vaccines, Ovine Vaccines

4) By Companion Animal Vaccines: Canine Vaccines, Feline Vaccines, Ferret Vaccines

5) By Aquaculture Vaccines: Fish Vaccines, Shrimp Vaccines

6) By Other Animal Vaccines: Wildlife Vaccines, Exotic Animal Vaccines

Poultry Vaccines Market Innovation Trends: What Developments Are Reshaping The Industry?

Leading companies in the poultry vaccine market are concentrating on developing novel technological solutions to reinforce their market position. These new technological solutions encompass advanced vaccine formulations, sophisticated delivery systems, and improved diagnostic instruments, all designed to enhance disease prevention, efficacy, and overall poultry health management. For example, in October 2023, Zoetis Inc., a US-based animal health company, introduced Circomax. This porcine circovirus type 2 (PCV2) vaccine is available in two genotypes, ‘a’ and ‘b’. The vaccination’s aim is to protect against PCV2 risks, such as the three genotypes observed in the UK pig herd, and to provide broader coverage. This particular PCV2 vaccination is the only one licensed to offer protection against all three genotypes, having demonstrated efficacy against PCV2a, PCV2b, and PCV2d. By launching CircoMax, Zoetis seeks to anticipate the evolution of PCV2 genotypes and to deliver high levels of efficacy, convenience, and proven safety for healthy piglets.

Poultry Vaccines Market Competitive Overview And Top Companies

Major companies operating in the poultry vaccines market are Merck & Co Inc., Boehringer Ingelheim International GmbH, Zoetis Inc., Ringpu Biology, MSD Animal Health, Elanco Animal Health Incorporated, Ceva Santé Animale S.A., Phibro Animal Health Corporation, Huvepharma AD, Venkys India Limited, Vetoquinol S.A., Indian Immunologicals Limited, Vaccination Services Pvt Ltd., Indovax Private Limited, Bio-Vet Inc., Hester Biosciences Limited, Intervet Inc., Anicon Labor GmbH, CZ Veterinaria S.A., Bioproperties Pty Ltd, Bioveta a.s., Aptimmune Biologics Inc., HIPRA S.A., Biovac (Pty) Ltd., Nisseiken Co Ltd., Zydus Animal Health Limited, Jinyu Bio-Technology Co Ltd., Kyoto Biken Laboratories Inc.

View The Full Poultry Vaccines Market Report:

https://thebusinessresearchcompany.com/report/poultry-vaccines-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Poultry Vaccines Market Top Region: Where Does Most Revenue Come From?

North America was the largest region in the poultry vaccines market in 2025. The regions covered in the poultry vaccines market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Reach Out To Our Team:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.

#Poultry Vaccines Market Forecast: Value Set To Climb From $2.12 Billion To $3.04 Billion#_x000D_

The poultry vaccines market size has demonstrated robust expansion over recent years. Its valuation is projected to increase from $1.94 billion in 2025 to $2.12 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 9.4%. Historically, this market’s expansion was driven by factors such as outbreaks of avian diseases, an uptick in poultry consumption, advancements in traditional vaccine development, heightened veterinary awareness at the farm level, and the growth of commercial poultry farming._x000D_

_x000D_

The poultry vaccines market size is projected to experience substantial growth in the upcoming years. By 2030, it is anticipated to expand to $3.04 billion, demonstrating a compound annual growth rate (CAGR) of 9.5%. This projected growth during the forecast period can be attributed to the rise of recombinant and DNA vaccines, the adoption of precision poultry vaccination programs, technological advancements in vaccine delivery systems, government initiatives aimed at improving poultry health, and an increasing focus on biosecurity measures within poultry farms. Major trends expected in this period include the increased usage of live and inactivated poultry vaccines, a greater emphasis on disease prevention in broilers and layers, the broader application of recombinant and DNA vaccines, the integration of vaccination programs with broader farm management practices, and the development of robust cold chain infrastructure for poultry vaccine distribution._x000D_

_x000D_

#Get A Free Sample Report With In-Depth Market Insights:#_x000D_

https://thebusinessresearchcompany.com/sample_request?id=8622&type=smp&name=Poultry%20Vaccines%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR_x000D_

_x000D_

#Poultry Vaccines Market Demand Drivers: What’s Powering Industry Growth?#_x000D_

The escalating occurrence of zoonotic diseases is anticipated to stimulate the expansion of the poultry vaccine market in the coming period. These common diseases are caused by pathogenic germs such as viruses, bacteria, parasites, and fungi. The growing prevalence of zoonotic diseases is increasing due to heightened human–animal interaction, as expanding urbanization and livestock farming lead to closer contact between people and animals. The poultry vaccine market is bolstered by the rising prevalence of zoonotic diseases, given that elevated disease risks necessitate vaccination to hinder the transmission of infections from poultry to humans and safeguard the health of flocks. For instance, in December 2025, according to European Centre for Disease Prevention and Control, a Sweden-based government agency, in 2024, the five most reported zoonoses in humans were campylobacteriosis, with 168,396 cases (55.3 cases per 100,000 people), salmonellosis, with 79,703 cases (18.6 cases per 100,000 people), Shiga toxin-producing Escherichia coli (STEC) infections, with 11,738 cases (3.5 cases per 100,000 people) and echinococcosis, with 984 cases (0.22 cases per 100,000 people). Therefore, the increasing prevalence of zoonotic diseases is expected to drive the growth of poultry vaccines._x000D_

_x000D_

#Poultry Vaccines Market Segment Performance And Emerging Opportunities#_x000D_

The poultry vaccines market covered in this report is segmented – _x000D_

_x000D_

1) By Type: Porcine Vaccines, Poultry Vaccine, Livestock Vaccine, Companion Animal Vaccine, Aquaculture Vaccines, Other Animal Vaccines_x000D_

2) By Disease Type: Avain Influenza, Infectious Bronchitis _x000D_

3) By Dosage Form: Liquid Vaccine, Freeze Dried Vaccine, Duct_x000D_

4) By Technology: Toxoid, Live Attenuated Vaccines, Recombinant Vaccines, Inactivated Vaccines_x000D_

5) By Application: Broiler, Layer, Breeder _x000D_

_x000D_

Subsegments:_x000D_

1) By Porcine Vaccines: Inactivated Vaccines, Live Attenuated Vaccines, DNA Vaccines, Recombinant Vaccines, Toxoid Vaccines_x000D_

2) By Poultry Vaccines: Live Vaccines, Inactivated Vaccines, Recombinant Vaccines, Subunit Vaccines, DNA Vaccines_x000D_

3) By Livestock Vaccines: Bovine Vaccines, Swine Vaccines, Ovine Vaccines_x000D_

4) By Companion Animal Vaccines: Canine Vaccines, Feline Vaccines, Ferret Vaccines_x000D_

5) By Aquaculture Vaccines: Fish Vaccines, Shrimp Vaccines_x000D_

6) By Other Animal Vaccines: Wildlife Vaccines, Exotic Animal Vaccines_x000D_

_x000D_

#Poultry Vaccines Market Innovation Trends: What Developments Are Reshaping The Industry?#_x000D_

Leading companies in the poultry vaccine market are concentrating on developing novel technological solutions to reinforce their market position. These new technological solutions encompass advanced vaccine formulations, sophisticated delivery systems, and improved diagnostic instruments, all designed to enhance disease prevention, efficacy, and overall poultry health management. For example, in October 2023, Zoetis Inc., a US-based animal health company, introduced Circomax. This porcine circovirus type 2 (PCV2) vaccine is available in two genotypes, ‘a’ and ‘b’. The vaccination’s aim is to protect against PCV2 risks, such as the three genotypes observed in the UK pig herd, and to provide broader coverage. This particular PCV2 vaccination is the only one licensed to offer protection against all three genotypes, having demonstrated efficacy against PCV2a, PCV2b, and PCV2d. By launching CircoMax, Zoetis seeks to anticipate the evolution of PCV2 genotypes and to deliver high levels of efficacy, convenience, and proven safety for healthy piglets._x000D_

_x000D_

#Poultry Vaccines Market Competitive Overview And Top Companies#_x000D_

Major companies operating in the poultry vaccines market are Merck & Co Inc., Boehringer Ingelheim International GmbH, Zoetis Inc., Ringpu Biology, MSD Animal Health, Elanco Animal Health Incorporated, Ceva Santé Animale S.A., Phibro Animal Health Corporation, Huvepharma AD, Venkys India Limited, Vetoquinol S.A., Indian Immunologicals Limited, Vaccination Services Pvt Ltd., Indovax Private Limited, Bio-Vet Inc., Hester Biosciences Limited, Intervet Inc., Anicon Labor GmbH, CZ Veterinaria S.A., Bioproperties Pty Ltd, Bioveta a.s., Aptimmune Biologics Inc., HIPRA S.A., Biovac (Pty) Ltd., Nisseiken Co Ltd., Zydus Animal Health Limited, Jinyu Bio-Technology Co Ltd., Kyoto Biken Laboratories Inc. _x000D_

_x000D_

#View The Full Poultry Vaccines Market Report:#_x000D_

https://thebusinessresearchcompany.com/report/poultry-vaccines-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR_x000D_

_x000D_

#Poultry Vaccines Market Top Region: Where Does Most Revenue Come From?#_x000D_

North America was the largest region in the poultry vaccines market in 2025. The regions covered in the poultry vaccines market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_

_x000D_

#Reach Out To Our Team:#_x000D_

_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas: +1 310-496-7795_x000D_

Asia: +44 7882 955267 & +91 8897263534_x000D_

Europe: +44 7882 955267_x000D_

Email us at: marketing@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

How Will The Market Value Of The Poultry Vaccines Market Change Between 2026 And 2030?

The poultry vaccines market size has experienced robust growth in recent years. This market is projected to expand from $1.94 billion in 2025 to $2.12 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 9.4%. Historically, this expansion has been driven by factors such as outbreaks of avian diseases, an increase in poultry consumption, the advancement of traditional vaccines, heightened veterinary awareness at the farm level, and the growth of commercial poultry farming.

The poultry vaccines market is projected to experience substantial expansion in the coming years. It is anticipated to reach $3.04 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 9.5%. This projected growth during the forecast period can be primarily attributed to factors such as the rise of recombinant and DNA vaccines, the implementation of precision poultry vaccination programs, ongoing technological progress in vaccine delivery mechanisms, governmental efforts to promote poultry health, and a heightened emphasis on biosecurity practices within poultry farms. Key trends expected during this period involve the increased uptake of live and inactivated poultry vaccines, a concentrated effort on preventing diseases in broilers and layers, the broader application of recombinant and DNA vaccines, the incorporation of vaccination schedules into overall farm management strategies, and the establishment of robust cold chain infrastructure for distributing poultry vaccines.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8622&type=smp

Which Growth Drivers Are Expected To Support The Poultry Vaccines Market Forward?

The increasing prevalence of zoonotic diseases is expected to propel the growth of the poultry vaccine market going forward. Zoonotic diseases are a group of common diseases caused by pathogenic germs such as viruses, bacteria, parasites, and fungi. The increasing prevalence of zoonotic diseases is rising due to increased human–animal interaction, as expanding urbanization and livestock farming bring people and animals into closer contact. The poultry vaccine market supports the increasing prevalence of zoonotic diseases, as rising disease risks drive the need for vaccination to prevent the spread of infections from poultry to humans and ensure flock health. For instance, in December 2025, according to European Centre for Disease Prevention and Control, a Sweden-based government agency, in 2024, the five most reported zoonoses in humans were campylobacteriosis, with 168,396 cases (55.3 cases per 100,000 people), salmonellosis, with 79,703 cases (18.6 cases per 100,000 people), Shiga toxin-producing Escherichia coli (STEC) infections, with 11,738 cases (3.5 cases per 100,000 people) and echinococcosis, with 984 cases (0.22 cases per 100,000 people). Therefore, the increasing prevalence of zoonotic diseases is expected to drive the growth of poultry vaccines.

Which Segment Groups Define The Poultry Vaccines Market Landscape?

The poultry vaccines market covered in this report is segmented –

1) By Type: Porcine Vaccines, Poultry Vaccine, Livestock Vaccine, Companion Animal Vaccine, Aquaculture Vaccines, Other Animal Vaccines

2) By Disease Type: Avain Influenza, Infectious Bronchitis

3) By Dosage Form: Liquid Vaccine, Freeze Dried Vaccine, Duct

4) By Technology: Toxoid, Live Attenuated Vaccines, Recombinant Vaccines, Inactivated Vaccines

5) By Application: Broiler, Layer, Breeder

Subsegments:

1) By Porcine Vaccines: Inactivated Vaccines, Live Attenuated Vaccines, DNA Vaccines, Recombinant Vaccines, Toxoid Vaccines

2) By Poultry Vaccines: Live Vaccines, Inactivated Vaccines, Recombinant Vaccines, Subunit Vaccines, DNA Vaccines

3) By Livestock Vaccines: Bovine Vaccines, Swine Vaccines, Ovine Vaccines

4) By Companion Animal Vaccines: Canine Vaccines, Feline Vaccines, Ferret Vaccines

5) By Aquaculture Vaccines: Fish Vaccines, Shrimp Vaccines

6) By Other Animal Vaccines: Wildlife Vaccines, Exotic Animal Vaccines

What Trends Are Shaping The Poultry Vaccines Market Structure?

Major companies operating in the poultry vaccine market are focused on developing new technological solutions to strengthen their position. New technological solutions refer to advanced vaccine formulations, delivery systems, and diagnostic tools designed to enhance disease prevention, efficacy, and poultry health management. For instance, in October 2023, Zoetis Inc., a US-based animal health company launched Circomax. The porcine circovirus type 2 (PCV2) vaccine comes in two genotypes a and b. The goal of the vaccination is to defend against PCV2 risks, such as the three genotypes seen in the UK pig herd, and to offer broader coverage. The only PCV2 vaccination that is licensed to protect against all three genotypes is this one, which has shown protection against PCV2a, PCV2b, and PCV2d. With the introduction of CircoMax, Zoetis is attempting to keep ahead of the PCV2 genotype evolution and offer healthy piglets high levels of efficacy, convenience, and proven safety.

Which Organizations Are Involved In The Poultry Vaccines Market?

North America was the largest region in the poultry vaccines market in 2025. The regions covered in the poultry vaccines market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access The Complete Poultry Vaccines Market Report:

https://www.thebusinessresearchcompany.com/report/poultry-vaccines-global-market-report

Which Region Is The Primary Market For The Poultry Vaccines Market?

North America was the largest region in the poultry vaccines market in 2025. The regions covered in the poultry vaccines market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access a Customized Poultry Vaccines Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/sample.aspx?id=8622&type=smp

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

How Will The Market Value Of The Poultry Vaccines Market Change Between 2026 And 2030?

The poultry vaccines market size has experienced robust growth in recent years. This market is projected to expand from $1.94 billion in 2025 to $2.12 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 9.4%. Historically, this expansion has been driven by factors such as outbreaks of avian diseases, an increase in poultry consumption, the advancement of traditional vaccines, heightened veterinary awareness at the farm level, and the growth of commercial poultry farming.

The poultry vaccines market is projected to experience substantial expansion in the coming years. It is anticipated to reach $3.04 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 9.5%. This projected growth during the forecast period can be primarily attributed to factors such as the rise of recombinant and DNA vaccines, the implementation of precision poultry vaccination programs, ongoing technological progress in vaccine delivery mechanisms, governmental efforts to promote poultry health, and a heightened emphasis on biosecurity practices within poultry farms. Key trends expected during this period involve the increased uptake of live and inactivated poultry vaccines, a concentrated effort on preventing diseases in broilers and layers, the broader application of recombinant and DNA vaccines, the incorporation of vaccination schedules into overall farm management strategies, and the establishment of robust cold chain infrastructure for distributing poultry vaccines.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8622&type=smp

Which Growth Drivers Are Expected To Support The Poultry Vaccines Market Forward?

The increasing prevalence of zoonotic diseases is expected to propel the growth of the poultry vaccine market going forward. Zoonotic diseases are a group of common diseases caused by pathogenic germs such as viruses, bacteria, parasites, and fungi. The increasing prevalence of zoonotic diseases is rising due to increased human–animal interaction, as expanding urbanization and livestock farming bring people and animals into closer contact. The poultry vaccine market supports the increasing prevalence of zoonotic diseases, as rising disease risks drive the need for vaccination to prevent the spread of infections from poultry to humans and ensure flock health. For instance, in December 2025, according to European Centre for Disease Prevention and Control, a Sweden-based government agency, in 2024, the five most reported zoonoses in humans were campylobacteriosis, with 168,396 cases (55.3 cases per 100,000 people), salmonellosis, with 79,703 cases (18.6 cases per 100,000 people), Shiga toxin-producing Escherichia coli (STEC) infections, with 11,738 cases (3.5 cases per 100,000 people) and echinococcosis, with 984 cases (0.22 cases per 100,000 people). Therefore, the increasing prevalence of zoonotic diseases is expected to drive the growth of poultry vaccines.

Which Segment Groups Define The Poultry Vaccines Market Landscape?

The poultry vaccines market covered in this report is segmented –

1) By Type: Porcine Vaccines, Poultry Vaccine, Livestock Vaccine, Companion Animal Vaccine, Aquaculture Vaccines, Other Animal Vaccines

2) By Disease Type: Avain Influenza, Infectious Bronchitis

3) By Dosage Form: Liquid Vaccine, Freeze Dried Vaccine, Duct

4) By Technology: Toxoid, Live Attenuated Vaccines, Recombinant Vaccines, Inactivated Vaccines

5) By Application: Broiler, Layer, Breeder

Subsegments:

1) By Porcine Vaccines: Inactivated Vaccines, Live Attenuated Vaccines, DNA Vaccines, Recombinant Vaccines, Toxoid Vaccines

2) By Poultry Vaccines: Live Vaccines, Inactivated Vaccines, Recombinant Vaccines, Subunit Vaccines, DNA Vaccines

3) By Livestock Vaccines: Bovine Vaccines, Swine Vaccines, Ovine Vaccines

4) By Companion Animal Vaccines: Canine Vaccines, Feline Vaccines, Ferret Vaccines

5) By Aquaculture Vaccines: Fish Vaccines, Shrimp Vaccines

6) By Other Animal Vaccines: Wildlife Vaccines, Exotic Animal Vaccines

What Trends Are Shaping The Poultry Vaccines Market Structure?

Major companies operating in the poultry vaccine market are focused on developing new technological solutions to strengthen their position. New technological solutions refer to advanced vaccine formulations, delivery systems, and diagnostic tools designed to enhance disease prevention, efficacy, and poultry health management. For instance, in October 2023, Zoetis Inc., a US-based animal health company launched Circomax. The porcine circovirus type 2 (PCV2) vaccine comes in two genotypes a and b. The goal of the vaccination is to defend against PCV2 risks, such as the three genotypes seen in the UK pig herd, and to offer broader coverage. The only PCV2 vaccination that is licensed to protect against all three genotypes is this one, which has shown protection against PCV2a, PCV2b, and PCV2d. With the introduction of CircoMax, Zoetis is attempting to keep ahead of the PCV2 genotype evolution and offer healthy piglets high levels of efficacy, convenience, and proven safety.

Which Organizations Are Involved In The Poultry Vaccines Market?

North America was the largest region in the poultry vaccines market in 2025. The regions covered in the poultry vaccines market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access The Complete Poultry Vaccines Market Report:

https://www.thebusinessresearchcompany.com/report/poultry-vaccines-global-market-report

Which Region Is The Primary Market For The Poultry Vaccines Market?

North America was the largest region in the poultry vaccines market in 2025. The regions covered in the poultry vaccines market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access a Customized Poultry Vaccines Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/sample.aspx?id=8622&type=smp

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Will Be The Estimated Market Valuation Of The Anti-Neoplastic Agents Market By The End Of 2030?

The poultry vaccines market size has demonstrated strong growth in recent years. It is forecast to expand from $1.94 billion in 2025 to $2.12 billion in 2026, at a compound annual growth rate (CAGR) of 9.4%. The historical growth can be attributed to factors like outbreaks of avian diseases, increasing poultry consumption, the development of traditional vaccines, rising farm-level veterinary awareness, and the expansion of commercial poultry farming.

The poultry vaccines market size is anticipated to experience substantial growth in the coming years. It will expand to **$3.04 billion in 2030 at a compound annual growth rate (CAGR) of 9.5%.** The expansion during this forecast period is attributable to the increasing development of recombinant and DNA vaccines, the adoption of precise poultry vaccination programs, technological improvements in vaccine delivery systems, government initiatives aimed at poultry health, and a rising focus on biosecurity measures within poultry farms. Significant trends expected during the forecast period include the greater use of live and inactivated poultry vaccines, an emphasis on preventing diseases in broilers and layers, the broader application of recombinant and DNA vaccines, the integration of vaccination strategies with general farm management practices, and the enhancement of cold chain infrastructure for distributing poultry vaccines.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8622&type=smp

Which Market Drivers Are Supporting The Expansion Of The Anti-Neoplastic Agents Market?

The rising occurrence of zoonotic diseases is projected to boost the expansion of the poultry vaccine market moving forward. Zoonotic diseases encompass a range of common illnesses caused by pathogenic microorganisms such as viruses, bacteria, parasites, and fungi. The heightened incidence of zoonotic diseases is increasing due to greater human–animal interaction, as expanding urbanization and livestock farming bring people and animals into closer contact. The poultry vaccine market addresses the increasing prevalence of zoonotic diseases, with escalating disease risks prompting the necessity for vaccination to prevent the spread of infections from poultry to humans and ensure the health of flocks. For instance, in December 2025, according to European Centre for Disease Prevention and Control, a Sweden-based government agency, in 2024, the five most reported zoonoses in humans were campylobacteriosis, with 168,396 cases (55.3 cases per 100,000 people), salmonellosis, with 79,703 cases (18.6 cases per 100,000 people), Shiga toxin-producing Escherichia coli (STEC) infections, with 11,738 cases (3.5 cases per 100,000 people) and echinococcosis, with 984 cases (0.22 cases per 100,000 people). Consequently, the growing prevalence of zoonotic diseases is anticipated to drive the growth of poultry vaccines.

Which Segment Classifications Shape The Anti-Neoplastic Agents Market?

The poultry vaccines market covered in this report is segmented –

1) By Type: Porcine Vaccines, Poultry Vaccine, Livestock Vaccine, Companion Animal Vaccine, Aquaculture Vaccines, Other Animal Vaccines

2) By Disease Type: Avain Influenza, Infectious Bronchitis

3) By Dosage Form: Liquid Vaccine, Freeze Dried Vaccine, Duct

4) By Technology: Toxoid, Live Attenuated Vaccines, Recombinant Vaccines, Inactivated Vaccines

5) By Application: Broiler, Layer, Breeder

Subsegments:

1) By Porcine Vaccines: Inactivated Vaccines, Live Attenuated Vaccines, DNA Vaccines, Recombinant Vaccines, Toxoid Vaccines

2) By Poultry Vaccines: Live Vaccines, Inactivated Vaccines, Recombinant Vaccines, Subunit Vaccines, DNA Vaccines

3) By Livestock Vaccines: Bovine Vaccines, Swine Vaccines, Ovine Vaccines

4) By Companion Animal Vaccines: Canine Vaccines, Feline Vaccines, Ferret Vaccines

5) By Aquaculture Vaccines: Fish Vaccines, Shrimp Vaccines

6) By Other Animal Vaccines: Wildlife Vaccines, Exotic Animal Vaccines

How Are Trends Impacting The Poultry Vaccines Market?

Major companies operating in the poultry vaccine market are intensifying efforts to develop advanced technological solutions to solidify their market position. These innovative solutions include sophisticated vaccine formulations, enhanced delivery systems, and cutting-edge diagnostic tools, all engineered to improve disease prevention, boost efficacy, and optimize poultry health management. For instance, in October 2023, Zoetis Inc., a US-based animal health company, introduced Circomax. This porcine circovirus type 2 (PCV2) vaccine comes in two genotypes, a and b. The vaccination aims to protect against PCV2 risks, such as the three genotypes identified in the UK pig herd, and to provide broader coverage. This particular PCV2 vaccination is the only one licensed to offer protection against all three genotypes, having demonstrated its efficacy against PCV2a, PCV2b, and PCV2d. With the debut of CircoMax, Zoetis is striving to stay ahead of the PCV2 genotype evolution and deliver high levels of efficacy, convenience, and proven safety for healthy piglets.

Which Companies Are Expanding Their Footprint In The Anti-Neoplastic Agents Market?

Major companies operating in the poultry vaccines market are Merck & Co Inc., Boehringer Ingelheim International GmbH, Zoetis Inc., Ringpu Biology, MSD Animal Health, Elanco Animal Health Incorporated, Ceva Santé Animale S.A., Phibro Animal Health Corporation, Huvepharma AD, Venkys India Limited, Vetoquinol S.A., Indian Immunologicals Limited, Vaccination Services Pvt Ltd., Indovax Private Limited, Bio-Vet Inc., Hester Biosciences Limited, Intervet Inc., Anicon Labor GmbH, CZ Veterinaria S.A., Bioproperties Pty Ltd, Bioveta a.s., Aptimmune Biologics Inc., HIPRA S.A., Biovac (Pty) Ltd., Nisseiken Co Ltd., Zydus Animal Health Limited, Jinyu Bio-Technology Co Ltd., Kyoto Biken Laboratories Inc.

Read the full poultry vaccines market report here:

https://www.thebusinessresearchcompany.com/report/poultry-vaccines-global-market-report

How Is The Anti-Neoplastic Agents Market Distributed Across Key Geographic Regions?

North America was the largest region in the poultry vaccines market in 2025. The regions covered in the poultry vaccines market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Anti-Neoplastic Agents Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=8622&type=smp

Browse Through More Reports Similar to the Global Poultry Vaccines Market 2026, By The Business Research Company

Veterinary Vaccines Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/veterinary-vaccines-global-market-report

Chickenpox Vaccine Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/chickenpox-vaccine-global-market-report

Vaccines Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/vaccines-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the direct-to-consumer (d2c) brands market from 2026–2035 with trusted insights from The Business Research Company

By how much is the Poultry Vaccines Market expected to grow between 2026 and 2030?

The poultry vaccines market size has shown significant growth over recent years. This market is anticipated to expand from $1.94 billion in 2025 to $2.12 billion in 2026, progressing at a compound annual growth rate (CAGR) of 9.4%. The expansion observed in past periods can be linked to factors such as outbreaks of avian diseases, increasing poultry consumption, the development of traditional vaccines, enhanced veterinary awareness at the farm level, and the broader expansion of commercial poultry farming.

The poultry vaccines market size is projected to experience substantial expansion over the coming years, reaching $3.04 billion by 2030, driven by a compound annual growth rate (CAGR) of 9.5%. This anticipated growth stems from several factors, including the increasing development of recombinant and DNA vaccines, the implementation of precise poultry vaccination strategies, advancements in vaccine administration technologies, governmental efforts to promote poultry health, and an elevated emphasis on biosecurity measures within poultry farms. Key trends anticipated during this period encompass the widespread use of both live and inactivated poultry vaccines, a heightened focus on preventing diseases in both broiler and layer chickens, the broader application of recombinant and DNA vaccines, the incorporation of vaccination schedules into overall farm management, and the establishment of robust cold chain systems for distributing poultry vaccines.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8622&type=smp

Which Drivers Are Influencing Market Acceleration In The Poultry Vaccines Market?

The escalating occurrence of zoonotic diseases is expected to drive the expansion of the poultry vaccine market in the future. These diseases are a category of widespread illnesses caused by infectious microorganisms such as viruses, bacteria, parasites, and fungi. The rising incidence of zoonotic diseases is attributed to increased interaction between humans and animals, as burgeoning urbanization and livestock farming bring populations and animals into closer contact. The poultry vaccine market plays a crucial role in managing the increasing prevalence of zoonotic diseases, as heightened disease risks necessitate vaccination to prevent the transmission of infections from poultry to humans and safeguard flock health. For instance, in December 2025, the European Centre for Disease Prevention and Control, a Sweden-based government agency, reported that in 2024, the five most frequently documented zoonoses in humans included campylobacteriosis, with 168,396 cases (55.3 cases per 100,000 people), salmonellosis, with 79,703 cases (18.6 cases per 100,000 people), Shiga toxin-producing Escherichia coli (STEC) infections, with 11,738 cases (3.5 cases per 100,000 people) and echinococcosis, with 984 cases (0.22 cases per 100,000 people). Consequently, the growing prevalence of zoonotic diseases is anticipated to fuel the growth of poultry vaccines.

What Segments Are Identified Within The Structure Of The Poultry Vaccines Market?

The poultry vaccines market covered in this report is segmented –

1) By Type: Porcine Vaccines, Poultry Vaccine, Livestock Vaccine, Companion Animal Vaccine, Aquaculture Vaccines, Other Animal Vaccines

2) By Disease Type: Avain Influenza, Infectious Bronchitis

3) By Dosage Form: Liquid Vaccine, Freeze Dried Vaccine, Duct

4) By Technology: Toxoid, Live Attenuated Vaccines, Recombinant Vaccines, Inactivated Vaccines

5) By Application: Broiler, Layer, Breeder

Subsegments:

1) By Porcine Vaccines: Inactivated Vaccines, Live Attenuated Vaccines, DNA Vaccines, Recombinant Vaccines, Toxoid Vaccines

2) By Poultry Vaccines: Live Vaccines, Inactivated Vaccines, Recombinant Vaccines, Subunit Vaccines, DNA Vaccines

3) By Livestock Vaccines: Bovine Vaccines, Swine Vaccines, Ovine Vaccines

4) By Companion Animal Vaccines: Canine Vaccines, Feline Vaccines, Ferret Vaccines

5) By Aquaculture Vaccines: Fish Vaccines, Shrimp Vaccines

6) By Other Animal Vaccines: Wildlife Vaccines, Exotic Animal Vaccines

What Industry Trends Are Transforming The Poultry Vaccines Market?

Leading companies active in the poultry vaccine market are concentrating on developing new technological solutions to reinforce their market position. These new technological solutions refer to advanced vaccine formulations, improved delivery systems, and sophisticated diagnostic tools, all designed to enhance disease prevention, overall effectiveness, and the management of poultry health. For instance, in October 2023, Zoetis Inc., a US-based animal health company, introduced Circomax. This porcine circovirus type 2 (PCV2) vaccine is available in two genotypes, a and b. The vaccination aims to defend against PCV2 risks, such as the three genotypes prevalent in the UK pig herd, and to provide broader coverage. It is the only PCV2 vaccination licensed to offer protection against all three genotypes, having demonstrated efficacy against PCV2a, PCV2b, and PCV2d. With the launch of CircoMax, Zoetis endeavors to anticipate the evolution of PCV2 genotypes and deliver high levels of efficacy, convenience, and proven safety for healthy piglets.

Which Major Firms Are Strengthening Their Position In The Poultry Vaccines Market?

Major companies operating in the poultry vaccines market are Merck & Co Inc., Boehringer Ingelheim International GmbH, Zoetis Inc., Ringpu Biology, MSD Animal Health, Elanco Animal Health Incorporated, Ceva Santé Animale S.A., Phibro Animal Health Corporation, Huvepharma AD, Venkys India Limited, Vetoquinol S.A., Indian Immunologicals Limited, Vaccination Services Pvt Ltd., Indovax Private Limited, Bio-Vet Inc., Hester Biosciences Limited, Intervet Inc., Anicon Labor GmbH, CZ Veterinaria S.A., Bioproperties Pty Ltd, Bioveta a.s., Aptimmune Biologics Inc., HIPRA S.A., Biovac (Pty) Ltd., Nisseiken Co Ltd., Zydus Animal Health Limited, Jinyu Bio-Technology Co Ltd., Kyoto Biken Laboratories Inc.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/poultry-vaccines-global-market-report

Which Region Is Anticipated To See The Fastest Growth In The Poultry Vaccines Market?

North America was the largest region in the poultry vaccines market in 2025. The regions covered in the poultry vaccines market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Poultry Vaccines Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=8622&type=smp

Browse Through More Reports Similar to the Global Poultry Vaccines Market 2026, By The Business Research Company

Veterinary Vaccines Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/veterinary-vaccines-global-market-report

Chickenpox Vaccine Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/chickenpox-vaccine-global-market-report

Vaccines Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/vaccines-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Uncover key drivers, emerging technologies, and competitive movements shaping the poultry vaccines market from 2025–2034 with trusted insights from The Business Research Company

What Are The Market Size Estimates For The Poultry Vaccines Market Now And By 2029?

The overall scale of the poultry vaccine sector has experienced robust expansion lately; projections indicate a rise from a valuation of $1.79 billion in 2024 to $1.94 billion throughout 2025, reflecting an 8.4% compounded annual growth rate over this timeframe. This acceleration observed in past periods stems from several key factors, including the incidence of widespread disease outbreaks, the increasing international commerce of poultry products, evolving preferences among consumers, rising environmental awareness, the emergence of novel infectious illnesses, and a heightened emphasis on seeking substitutes for traditional antibiotics.

Projected to exhibit robust expansion over the coming years, the poultry vaccines sector anticipates reaching a valuation of $2.78 billion by 2029, driven by a compound annual growth rate (CAGR) of 9.5%; this progressive trajectory is fueled by factors such as the constant alteration and development of diseases, the worldwide proliferation of the poultry farming sector, escalating consumer need for protein-dense foodstuffs, growing attention to ecological considerations and long-term viability, alongside an intensifying emphasis on the ethical treatment of animals. Key shifts anticipated to shape this time frame encompass the integration of digital technologies into vaccine administration processes, a growing pursuit of substitutes for traditional antibiotics, improvements in production throughput, the appearance of novel contagious illnesses, and ongoing environmental considerations.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8622&type=smp

Which Long-Term Drivers Are Expected To Sustain The Poultry Vaccines Market?

The rising incidence of diseases transmissible from animals to humans is projected to significantly boost the expansion of the market for poultry vaccines. These zoonotic ailments, which stem from infectious agents like fungi, parasites, bacteria, and viruses, are becoming more common. Factors such as transformations in land utilization patterns and heightened urban development contribute to the emergence of these illnesses by intensifying contact between people and animals and accelerating how quickly they spread; habitat destruction, climate shifts, and greater urbanization elevate the risk associated with zoonotic conditions. Because there is a growing occurrence of these cross-species diseases, the need for vaccines targeting poultry is escalating. As an illustration, a July 2022 publication by the World Health Organization noted that zoonotic cases in Africa had climbed by 64 percent, referencing data from a US government entity. Moreover, these infections are multiplying globally, including within India, where 60 percent of emergent infectious disease cases in people are attributable to zoonotic origins, encompassing 816 out of 1407 identified human pathogens. Consequently, the greater frequency of diseases originating in animals is anticipated to be a key factor fueling the growth trajectory of poultry vaccines.

How Is The Poultry Vaccines Market Classified By Different Segments?

The poultry vaccines market covered in this report is segmented –

1) By Type: Porcine Vaccines, Poultry Vaccine, Livestock Vaccine, Companion Animal Vaccine, Aquaculture Vaccines, Other Animal Vaccines

2) By Disease Type: Avain Influenza, Infectious Bronchitis

3) By Dosage Form: Liquid Vaccine, Freeze Dried Vaccine, Duct

4) By Technology: Toxoid, Live Attenuated Vaccines, Recombinant Vaccines, Inactivated Vaccines

5) By Application: Broiler, Layer, Breeder

Subsegments:

1) By Porcine Vaccines: Inactivated Vaccines, Live Attenuated Vaccines, DNA Vaccines, Recombinant Vaccines, Toxoid Vaccines

2) By Poultry Vaccines: Live Vaccines, Inactivated Vaccines, Recombinant Vaccines, Subunit Vaccines, DNA Vaccines

3) By Livestock Vaccines: Bovine Vaccines, Swine Vaccines, Ovine Vaccines

4) By Companion Animal Vaccines: Canine Vaccines, Feline Vaccines, Ferret Vaccines

5) By Aquaculture Vaccines: Fish Vaccines, Shrimp Vaccines

6) By Other Animal Vaccines: Wildlife Vaccines, Exotic Animal Vaccines

What Current And Upcoming Trends Are Shaping The Poultry Vaccines Market?

The poultry vaccines market is seeing a significant boost driven by ongoing progress in technology, establishing these advancements as a crucial trend. Innovations and new technologies have positioned vaccines as the primary method for preventing sickness in poultry, offering both high effectiveness and economical value. Leading firms within this sector are concentrating their efforts on creating novel technological remedies to solidify their standing. As an illustration, in October of 2023, Zoetis Inc., an American animal health enterprise, introduced Circomax. This vaccine targeting porcine circovirus type 2 (PCV2) is available in two distinct genotypes, namely a and b. Its intended purpose is to provide defense against PCV2 hazards, including the three strains observed in the United Kingdom’s swine population, thus ensuring more comprehensive protection. Being the sole licensed PCV2 vaccination capable of offering protection across all three genotypes, it has demonstrated efficacy against PCV2a, PCV2b, and PCV2d. Through the rollout of CircoMax, Zoetis aims to maintain a lead over the evolving PCV2 genotypes while simultaneously delivering piglets excellent protection, ease of use, and reliably demonstrated safety.

Who Are The Primary Market Leaders In The Poultry Vaccines Market?

Major companies operating in the poultry vaccines market include Merck & Co Inc., Boehringer Ingelheim International GmbH, Zoetis Inc., Ringpu Biology, MSD Animal Health, Elanco Animal Health Incorporated, Ceva Santé Animale S.A., Phibro Animal Health Corporation, Huvepharma AD, Venkys India Limited, Vetoquinol S.A., Indian Immunologicals Limited, Vaccination Services Pvt Ltd., Indovax Private Limited, Bio-Vet Inc., Hester Biosciences Limited, Intervet Inc., Anicon Labor GmbH, CZ Veterinaria S.A., Bioproperties Pty Ltd, Bioveta a.s., Aptimmune Biologics Inc., HIPRA S.A., Biovac (Pty) Ltd., Nisseiken Co Ltd., Zydus Animal Health Limited, Jinyu Bio-Technology Co Ltd., Kyoto Biken Laboratories Inc.

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/poultry-vaccines-global-market-report

Which Regional Markets Are Emerging As Key Centers For The Poultry Vaccines Market?

North America was the largest region in the poultry vaccines market in 2024. The regions covered in the poultry vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=8622&type=smp

Browse Through More Reports Similar to the Global Poultry Vaccines Market 2025, By The Business Research Company

Veterinary Vaccines Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/veterinary-vaccines-global-market-report

Companion Animal Veterinary Vaccines Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/companion-animal-veterinary-vaccines-global-market-report

Poultry Healthcare Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/poultry-healthcare-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model